Gilead Publishes 2025 Responsible Business and Impact Report, Highlighting Momentum Toward 2030 Ambitions

Back

FOSTER CITY, Calif., April 21, 2026 — Gilead Sciences, Inc. today published its 2025 Responsible Business and Impact Report, outlining progress toward our 2030 ambitions and the priorities guiding our next phase of work: advancing breakthrough innovation, accelerating access at scale, investing in people and communities, and embedding sustainability across operations.

Among the progress reflected in this report:

Advancing next-generation innovation across virology, oncology and inflammation, supported by 50+ clinical-stage programs—our most robust pipeline in company history.
Designing access into the lifecycle of innovation, including steps to accelerate global access for our twice-yearly injectable HIV prevention medicine, with voluntary licensing covering 120 low- and lower-middle-income countries and partnerships intended to help bridge near-term access gaps.
Strengthening health systems in the U.S. and globally through initiatives such as FOCUS, supporting routine screening and linkage to care for HIV, hepatitis B and hepatitis C, with partners performing more than 24.7 million screening tests in underserved communities.
Investing in the communities where our employees live and work, through the Gilead Foundation and corporate giving programs, with $260M+ awarded in 2025 to help address social determinants of health, including STEM education, healthcare workforce pathways, food security and community resilience.
Advancing sustainability outcomes aligned with measurable, globally recognized benchmarks, including achieving ~100% renewable electricity in our operations and verified zero-waste-to-landfill performance at our Foster City headquarters.
Continuing long-term investment in U.S. innovation and manufacturing capabilities, including groundbreaking for a new research and manufacturing development center at our Foster City headquarters as part of a multi-year U.S. investment commitment through 2030.

Gilead's 2025 Responsible Business and Impact Report is available here, accompanied by a Reporting Appendix with additional performance data and reporting standards alignment.

For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).